Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 253
  • Home
  • Print this page
  • Email this page

    Article Cited by others


Seeking optimal management for radioactive iodine therapy-induced adverse effects

Charalambous Andreas

Year : 2017| Volume: 4| Issue : 4 | Page no: 319-322

   This article has been cited by
1 Reduction of Salivary Gland Damage During Radioiodine Therapy for Differentiated Thyroid Cancers
Byeong-Cheol Ahn
Nuclear Medicine and Molecular Imaging. 2020;
[Pubmed]  [Google Scholar] [DOI]
2 Current alternatives in the prevention and treatment of xerostomia in cancer therapy
Tainara BARBIERI,Kiany Claudia da COSTA,Letķcia de Freitas Cuba GUERRA
RGO - Revista Gaścha de Odontologia. 2020; 68
[Pubmed]  [Google Scholar] [DOI]
3 Recombinant Human Thyrotropin-Stimulated Radioiodine Therapy in Patients with Multinodular Goiters: A Meta-Analysis of Randomized Controlled Trials
Chunmei Xu,Ping Wang,Huikai Miao,Tianyue Xie,Xiaojun Zhou,Qian Zhang,Shan Jiang,Rui Zhang,Lin Liao,Jianjun Dong
Hormone and Metabolic Research. 2020;
[Pubmed]  [Google Scholar] [DOI]
4 Radioactive Iodine Induced Hyposalivation:Case Report
Qingcong Zeng,Louis Mandel
Journal of Oral and Maxillofacial Surgery. 2019;
[Pubmed]  [Google Scholar] [DOI]


Read this article